Advisory group calls for members

Medicines Australia and AusBiotech are calling on members to join a newly launched advisory group to accelerate advanced therapies in Australia.

The Advanced Therapies Advisory Group will lead policy development and advocacy across critical areas, including manufacturing capacity, workforce, and strengthening patient pathways to new therapies.

The launch coincides with the release of the Australian Cell and Gene Therapies Investment Report in partnership with Deloitte which found 91 per cent of respondents agree national coordination is essential to advance Australia’s capabilities.